Arena Pharmaceuticals Inc (NASDAQ:ARNA)

40.38
Delayed Data
As of Apr 25
 +0.37 / +0.92%
Today’s Change
11.30
Today|||52-Week Range
45.85
+18.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line-22.5M-23.6M-30.6M-13.4M
 
 
 
 
 
Depreciation1.8M1.8M1.8M-1.2M
 
 
 
 
 
Total Other Cash Flow1.9M1.8M11.8M-4.5M
 
 
 
 
 
Funds From Operations-18.8M-20.0M-17.0M-19.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.5M5.9M1.4M-12.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-16.3M-25.9M-18.3M-6.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-112.6M
 
 
Capital Expenditures-49.0K-41.0K-1.0K-22.0K
 
 
 
 
 
Fixed Asset Disposal0.000.00789.0K0.00
 
 
Other Investing - Uses0.000.000.00-446.0K
 
 
Other Investing - Sources94.0K-4.0K1.0K--
 
 
 
 
Net Cash Flow Investing45.0K-45.0K789.0K-113.2M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction-816.0K-868.0K-904.0K-930.0K
 
 
 
 
 
Net Proceeds Stock Sale5.3M76.2M166.8M476.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing4.5M75.4M165.9M-454.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash578.0K1.8M-434.0K-120.0K
 
 
 
 
 
 
Net Change In Cash-11.8M49.4M148.4M-119.8M